Trials / Completed
CompletedNCT04145128
A Study to Evaluate AG-881 in Healthy Japanese and Non-Asian Participants
A Phase 1, Open-Label, Single Ascending Dose Study to Evaluate AG-881 in Healthy Japanese and Non-Asian Subjects
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 32 (actual)
- Sponsor
- Agios Pharmaceuticals, Inc. · Industry
- Sex
- All
- Age
- 18 Years – 55 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this study is to compare the pharmacokinetics (PK) and safety of AG-881 in healthy Japanese and Non-Asian participants after single oral doses of 10 mg and 50 mg of AG-881.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | AG881 | AG-881 tablets. |
Timeline
- Start date
- 2019-10-02
- Primary completion
- 2019-12-11
- Completion
- 2019-12-18
- First posted
- 2019-10-30
- Last updated
- 2020-04-02
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT04145128. Inclusion in this directory is not an endorsement.